UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.929

Sortiert nach

Meta‐analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma

Alimentary pharmacology & therapeutics, 2008-11, Vol.28 (9), p.1067-1077

2008

Link zum Volltext

Verfügbarkeit prüfen

Hepatocellular Carcinoma and Hepatitis B Virus

Seminars in liver disease, 2006-05, Vol.26 (2), p.153-161

2006

Link zum Volltext

Verfügbarkeit prüfen

Shorter durations and lower doses of peginterferon alfa‐2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C

Hepatology (Baltimore, Md.), 2011-11, Vol.54 (5), p.1591-1599

2011

Link zum Volltext

Verfügbarkeit prüfen

Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma

Gut, 2004-10, Vol.53 (10), p.1494-1498

2004

Link zum Volltext

Verfügbarkeit prüfen

Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment-naïve patients with HBV-related decompensated cirrhosis

Journal of viral hepatitis, 2012-10, Vol.19 (10), p.732-743

2012

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B

Journal of viral hepatitis, 2013-04, Vol.20 (4), p.e37-e46

2013

Link zum Volltext

Verfügbarkeit prüfen

Intrahepatic Hepatitis B Virus Covalently Closed Circular DNA Can Be a Predictor of Sustained Response to Therapy

Gastroenterology (New York, N.Y. 1943), 2005-06, Vol.128 (7), p.1890-1897

2005

Link zum Volltext

Verfügbarkeit prüfen

Identification of Chronic Hepatitis B Patients without Significant Liver Fibrosis by a Simple Noninvasive Predictive Model

The American journal of gastroenterology, 2005-03, Vol.100 (3), p.616-623

2005

Link zum Volltext

Verfügbarkeit prüfen

Different hepatitis b virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion

Hepatology (Baltimore, Md.), 1999-03, Vol.29 (3), p.976-984

1999

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B e antigen–negative chronic hepatitis b in Hong Kong

Hepatology (Baltimore, Md.), 2000-03, Vol.31 (3), p.763-768

2000

Link zum Volltext

Verfügbarkeit prüfen

Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection

The American journal of gastroenterology, 2002-02, Vol.97 (2), p.406-412

2002

Link zum Volltext

Verfügbarkeit prüfen

Long-term follow-up of peginterferon and lamivudine combination treatment in HBeAg-positive chronic hepatitis B

Hepatology (Baltimore, Md.), 2005-06, Vol.41 (6), p.1357-1364

2005

Link zum Volltext

Verfügbarkeit prüfen

Long-term Outcome of Helicobacter pylori–Negative Idiopathic Bleeding Ulcers: A Prospective Cohort Study

Gastroenterology (New York, N.Y. 1943), 2005-06, Vol.128 (7), p.1845-1850

2005

Link zum Volltext

Verfügbarkeit prüfen

Randomised clinical trial: efficacy of peginterferon alfa‐2a in HBeAg positive chronic hepatitis B patients with lamivudine resistance

Alimentary pharmacology & therapeutics, 2011-08, Vol.34 (4), p.424-431

2011

Link zum Volltext

Verfügbarkeit prüfen

Histological progression of non‐alcoholic fatty liver disease in Chinese patients

Alimentary pharmacology & therapeutics, 2005-02, Vol.21 (4), p.407-413

2005

Link zum Volltext

Verfügbarkeit prüfen

Systematic review: treatment of chronic hepatitis B virus infection by pegylated interferon

Alimentary pharmacology & therapeutics, 2005-09, Vol.22 (6), p.519-528

2005

Link zum Volltext

Verfügbarkeit prüfen

Occult HBV infection in cryptogenic liver cirrhosis in an area with high prevalence of HBV infection

The American journal of gastroenterology, 2002-05, Vol.97 (5), p.1211-1215

2002

Link zum Volltext

Verfügbarkeit prüfen

Survival and Prognostic Indicators in Patients with Hepatitis B Virus–Related Cirrhosis After Onset of Hepatic Decompensation

Journal of clinical gastroenterology, 2002-05, Vol.34 (5), p.569-572

2002

Link zum Volltext

Verfügbarkeit prüfen

Clinical and histological features of non‐alcoholic fatty liver disease in Hong Kong Chinese

Alimentary pharmacology & therapeutics, 2004-07, Vol.20 (1), p.45-49

2004

Link zum Volltext

Verfügbarkeit prüfen

Effect of celecoxib on experimental liver fibrosis in rat

Liver international, 2006-02, Vol.26 (1), p.125-136

2006

Link zum Volltext

Verfügbarkeit prüfen

A Retrospective Study on Clinical Features and Prognostic Factors of Biopsy-Proven Primary Biliary Cirrhosis in Chinese Patients

The American journal of gastroenterology, 2005-10, Vol.100 (10), p.2205-2211

2005

Link zum Volltext

Verfügbarkeit prüfen

Quantitative assessment of fibrosis in liver biopsies from patients with chronic hepatitis B

Liver international, 2004-12, Vol.24 (6), p.611-618

2004

Link zum Volltext

Verfügbarkeit prüfen

The role of lamivudine and predictors of mortality in severe flare-up of chronic hepatitis B with jaundice

Journal of viral hepatitis, 2002-11, Vol.9 (6), p.424-428

2002

Link zum Volltext

Verfügbarkeit prüfen

Is non- Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper GI bleeding? A prospective study of 977 patients

Gastrointestinal endoscopy, 2001-04, Vol.53 (4), p.438-442

2001

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B virus genotype has no impact on hepatitis B e antigen seroconversion after lamivudine treatment

World journal of gastroenterology : WJG, 2003-12, Vol.9 (12), p.2695

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.929

Suche als RSS-Feed

Aktive Filter

ThemaGastroenterology & Hepatology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.670)
Mit Volltextzugriff
(1.739)

Publikationsform

Artikel
(1.915)
Buchkapitel
(14)

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(1.922)
Science & Technology
(1.922)
Humans
(1.383)
Male
(769)
Female
(762)
Adult
(634)
Hepatitis B
(620)
Middle Aged
(613)
Hepatitis B Virus
(582)
Hepatitis B, Chronic - Drug Therapy
(549)
Antiviral Agents - Therapeutic Use
(536)
Hepatitis B Virus - Genetics
(458)
Hepatology
(414)
Hepatitis
(408)
Infectious Diseases
(399)
Treatment Outcome
(327)
Chronic Hepatitis B
(307)
Aged
(296)
Hepatocellular Carcinoma
(294)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Meta‐analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma

Hepatocellular Carcinoma and Hepatitis B Virus

Shorter durations and lower doses of peginterferon alfa‐2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C

Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma

Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment-naïve patients with HBV-related decompensated cirrhosis

Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B

Intrahepatic Hepatitis B Virus Covalently Closed Circular DNA Can Be a Predictor of Sustained Response to Therapy

Identification of Chronic Hepatitis B Patients without Significant Liver Fibrosis by a Simple Noninvasive Predictive Model

Different hepatitis b virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion

Hepatitis B e antigen–negative chronic hepatitis b in Hong Kong

Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection

Long-term follow-up of peginterferon and lamivudine combination treatment in HBeAg-positive chronic hepatitis B

Long-term Outcome of Helicobacter pylori–Negative Idiopathic Bleeding Ulcers: A Prospective Cohort Study

Randomised clinical trial: efficacy of peginterferon alfa‐2a in HBeAg positive chronic hepatitis B patients with lamivudine resistance

Histological progression of non‐alcoholic fatty liver disease in Chinese patients

Systematic review: treatment of chronic hepatitis B virus infection by pegylated interferon

Occult HBV infection in cryptogenic liver cirrhosis in an area with high prevalence of HBV infection

Survival and Prognostic Indicators in Patients with Hepatitis B Virus–Related Cirrhosis After Onset of Hepatic Decompensation

Clinical and histological features of non‐alcoholic fatty liver disease in Hong Kong Chinese

Effect of celecoxib on experimental liver fibrosis in rat

A Retrospective Study on Clinical Features and Prognostic Factors of Biopsy-Proven Primary Biliary Cirrhosis in Chinese Patients

Quantitative assessment of fibrosis in liver biopsies from patients with chronic hepatitis B

The role of lamivudine and predictors of mortality in severe flare-up of chronic hepatitis B with jaundice

Is non- Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper GI bleeding? A prospective study of 977 patients

Hepatitis B virus genotype has no impact on hepatitis B e antigen seroconversion after lamivudine treatment

Aktive Filter

Suchergebnisse filtern